Latest Commercial Partnerships News

Adisyn Ltd has completed a strategic review, deciding to boost investment in its graphene-based semiconductor arm while exploring options to unlock value from its managed IT services business.

Aurora Labs has secured its first $250,000 order for AU4 propulsion engines from Sovereign Propulsion Systems, marking a key step in its commercialisation strategy targeting unmanned aerial vehicles and defence markets.

The Minerals Development Company Botswana has increased its investment in Botala Energy’s Serowe coal bed methane project to approximately A$4 million, signaling strong government backing for the company’s LNG ambitions.

BrainChip Holdings has closed its Share Purchase Plan with subscriptions exceeding the $2 million target by nearly $1 million, complementing a recent $35 million placement. The Board’s decision to accept all applications reflects robust shareholder confidence.

Firebird Metals has secured a key patent for its energy-efficient kiln and announced plans for an Australian Demonstration Plant to commercialise its battery materials technology.

Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.

Temas Resources has completed a major drilling campaign at its La Blache project, targeting key critical minerals while progressing its innovative Regenerative Chloride Leach technology promising significant cost savings.

InhaleRx Limited has introduced SRX-25, an oral fixed-dose combination therapy targeting Treatment-Resistant Depression, aiming to improve patient access and adherence. The company also secured $1 million in capital to advance clinical development and plans a strategic rebrand.

Eclipse Metals has engaged BGR Group, a leading U.S. government relations firm, to strengthen its strategic positioning and funding prospects for its Greenland rare earth projects, advancing its role in Western critical minerals supply chains.

Mesoblast Limited forecasts a significant jump in quarterly revenue, driven by strong sales of its FDA-approved cell therapy Ryoncil. The company’s latest update highlights robust growth and ongoing expansion in inflammatory disease treatments.

Lithium Universe advances its U.S. solar panel recycling strategy following silver’s historic classification as a Critical Metal, positioning itself to tap into soaring demand and a growing PV waste stream.

Bio-Gene Technology Limited updates on its development of two novel insecticides, Flavocide and Qcide, highlighting regulatory progress, commercial partnerships, and a strong market outlook across multiple sectors.